menu
    • menu

    Company profile for Santen Pharmaceutical

    NEW Drugs in Dev: 31
    Evonik

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    End-to-end drug development, specializing in high-potency softgels and liquids, providing global partners with a competitive advantage.

    Virtual Booth

    Contact Supplier

    Kewpie is your partner for Sodium Hyaluronate & Hyaluronic Acid// CEP, USDMF, KDMF & JDMF registered.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    At Santen, we’re innovating therapies to improve the quality of life for patients worldwide. Our single focus in ophthalmology enables us to challenge unmet needs in the field—through passionate research, successful collaboration, and clarity of commitment. With over 120 years of investigative insight, Santen remains committed to the discovery, exploration, and development of ophthalmic therapies. Now, and into the future....
    At Santen, we’re innovating therapies to improve the quality of life for patients worldwide. Our single focus in ophthalmology enables us to challenge unmet needs in the field—through passionate research, successful collaboration, and clarity of commitment. With over 120 years of investigative insight, Santen remains committed to the discovery, exploration, and development of ophthalmic therapies. Now, and into the future. As a global company, Santen is often expanding to accommodate new and evolving initiatives in ophthalmic research, regulatory management, production, marketing, or distribution.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Santen Pharmaceuticaljapan Flag
    Country
    Country
    Japan
    Address
    Address
    Grand Front Osaka Tower A, 4-20 Ofuka-cho, Kita-ku, Osaka 530-8552
    Telephone
    Telephone
    +81-6-6321-7000
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.santen.com/en/
    Linkedin
    Linkedin
    https://in.linkedin.com/company/santen
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    RVL Pharma: Santen Gets Japan Approval For UPNEEQ Mini
    RVL Pharma: Santen Gets Japan Approval For UPNEEQ Mini

    08 Jan 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/rvl-pharmaceuticals-announces-santen-obtains-manufacturing-and-marketing-approval-in-japan-for-upneeq-mini-ophthalmic-solution-0-1-302655890.html

    PR NEWSWIRE
    08 Jan 2026
    Share Share
    Santen Gets UK Approval For Ryjunea To Slow Childhood Myopia
    Santen Gets UK Approval For Ryjunea To Slow Childhood Myopia

    13 Nov 2025

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2025-11-13/santen-receives-uk-approval-for-ryjunea-low-dose-atropine-01-mgml-to-slow-progression-of-childhood-myopia

    PHARMIWEB
    13 Nov 2025
    Share Share
    RemeGen, Santen ink exclusive deal for ophthalmic RC28-E Drug
    RemeGen, Santen ink exclusive deal for ophthalmic RC28-E Drug

    18 Aug 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/remegen-and-santen-enter-into-exclusive-licensing-agreement-for-ophthalmic-innovative-drug-rc28-e-in-greater-china-and-asian-countries-302532212.html

    PR NEWSWIRE
    18 Aug 2025
    Share Share
    Clearside Bio Partners with Arctic Vision for Uveitic Macular Edema
    Clearside Bio Partners with Arctic Vision for Uveitic Macular Edema

    07 Nov 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/11/07/2976768/0/en/Clearside-Biomedical-Partner-Arctic-Vision-Executes-Commercial-Collaboration-Agreement-with-Santen-Pharmaceutical-Co-Ltd-for-ARVN001-Suprachoroidal-Space-Injection-Therapy-for-the-.html

    GLOBENEWSWIRE
    07 Nov 2024
    Share Share
    NurExone’s ExoPTEN Being Studied as Glaucoma Treatment for US$3.4 Billion Market
    NurExone’s ExoPTEN Being Studied as Glaucoma Treatment for US$3.4 Billion Market

    28 Jun 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/06/28/2906122/0/en/NurExone-s-ExoPTEN-Being-Studied-as-Glaucoma-Treatment-for-US-3-4-Billion-Market.html

    GLOBENEWSWIRE
    28 Jun 2024
    Share Share
    Santen Agrees to Licensing Agreements for its Pharmaceutical Products
    Santen Agrees to Licensing Agreements for its Pharmaceutical Products

    18 Jul 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20230718106227/en

    BUSINESSWIRE
    18 Jul 2023
    Share Share

    USDMF

    read-more
    read-more

    01

    Cs-011 Drug Substance

    Japan
    VMX
    Not Confirmed
    arrow

    02

    Rimatil

    Japan
    VMX
    Not Confirmed
    arrow

    03

    Thiola

    Japan
    VMX
    Not Confirmed
    arrow

    04

    Tropicamide Mydriatic

    Japan
    VMX
    Not Confirmed
    arrow

    05

    Facilities And Procedures In Tampere...

    Japan
    VMX
    Not Confirmed
    arrow

    06

    Manufacturing Plant At Noto, Japan

    Japan
    VMX
    Not Confirmed
    arrow
    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    ABOUT THIS PAGE

    Contact Santen Pharmaceutical and get a quotation

    Santen Pharmaceutical is a supplier offers 7 products (APIs, Excipients or Intermediates).

    Find a price of Sennosides bulk with JDMF offered by Santen Pharmaceutical

    Find a price of Bucillamine bulk offered by Santen Pharmaceutical

    Find a price of Rivoglitazone Hydrochloride bulk offered by Santen Pharmaceutical

    Find a price of Tiopronin bulk offered by Santen Pharmaceutical

    Find a price of Tropicamide bulk offered by Santen Pharmaceutical

    Find a price of MANUFACTURING PLANT AT NOTO, JAPAN bulk offered by Santen Pharmaceutical

    Find a price of FACILITIES AND PROCEDURES IN TAMPERE, FINLAND bulk offered by Santen Pharmaceutical

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search